Merkel Cell Carcinoma - 3 Studies Found

Completed : Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
: Merkel Cell Carcinoma
: 2025-08-01
: Pembrolizumab 400mg IV
Completed : Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma
: Merkel Cell Carcinoma
: 2025-08-01
: 400mg IV
Completed : Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
: Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
: 2025-08-01
: Undergo tumor biopsy